Recombinant Human GIPR Protein，His

GIPR (Gastric Inhibitory Polypeptide Receptor) is a crucial member of the glucagon-like peptide receptor family, primarily involved in regulating glucose homeostasis and insulin secretion. Its role in adipogenesis and metabolism makes it a target of considerable interest in diabetes and obesity research. Recent studies have indicated that GIPR is expressed in various tissues, including pancreatic beta cells, adipose tissue, and the brain, suggesting it may play diverse physiological roles beyond its initial identification in the gastrointestinal system. The challenge in studying GIPR has been the difficulty in obtaining sufficient quantities of functional recombinant protein, which is essential for detailed molecular characterization and high-throughput screening of potential therapeutics. Advances in recombinant DNA technology and protein expression systems have opened new avenues for producing GIPR proteins, allowing researchers to investigate their structure, function, and interactions with ligands. This research is particularly relevant in the context of developing novel treatments for metabolic disorders, as understanding the detailed mechanisms of GIPR activity could lead to more effective strategies for managing insulin resistance and promoting metabolic health. Ultimately, the study of GIPR and the production of its recombinant protein offers significant promise for uncovering new insights into endocrine regulation and potential therapeutic interventions.